Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Australia in Vitro Diagnostics Investment Opportunities

Analysis and Forecasts to 2015

Publication Date April 2009
Publisher Global Markets Direct
Product Type Report
Pages 150
ISBN Number not applicable
Product Code GMD02522

Price

£1,650.00
approximately: $2,498 | €1,842

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

This report is an essential source for in-depth information and data relating to the Australia In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Australia

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Australia.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Australia.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 In Vitro Diagnostics Devices
    • 3.2 Clinical Chemistry Test Reagents
      • 3.2.1 Laboratory Reagents
      • 3.2.2 Clinical Chemistry Calibrators and Controls
      • 3.2.3 Clinical Chemistry Rapid Tests
    • 3.3 Immunochemistry Test Reagents
      • 3.3.1 Disease Specific Markers
      • 3.3.2 Disease Specific Test Reagents
      • 3.3.3 Drug Related Testing Reagents
      • 3.3.4 Hormone Related Testing Reagents
      • 3.3.5 Immunochemistry Calibrators and Controls
      • 3.3.6 Immunochemistry Rapid Tests
    • 3.4 Blood Test Reagents
      • 3.4.1 Hematology Test Reagents
      • 3.4.2 Hemostasis Test Reagents
      • 3.4.3 Tissue Typing Reagents
      • 3.4.4 Monoclonal Antibodies
      • 3.4.5 Cytokines and Immunomodulators
      • 3.4.6 Histology and Cytology Reagents
    • 3.5 Microbiology Test Reagents
      • 3.5.1 Bacteriology Test Reagents
      • 3.5.2 Microbiology Calibrators and Controls
      • 3.5.3 Microbiology Rapid Tests
    • 3.6 Infectious Immunology Test Reagents
      • 3.6.1 Bacteriology
      • 3.6.2 Virology
      • 3.6.3 Parasitology
      • 3.6.4 Infectious Immunology Calibrators and Controls
      • 3.6.5 Infectious Immunology Rapid Tests
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Registration and Conformity Assessment
    • 5.2 Advertising
    • 5.3 Labeling and Packaging
    • 5.4 Post-market Surveillance
    • 5.5 Registration Fee
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
  • 8 In Vitro Diagnostics In Australia
    • 8.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
    • 8.2 In Vitro Diagnostics, Australia Company Share (2006-2007)
  • 9 Blood Test Reagents In Australia
    • 9.1 Blood Test Reagents Overall Revenue (2000-2015)
      • 9.1.1 Haematology Test Reagents Revenue (2000-2015)
      • 9.1.2 Hemostasis Test Reagents Revenue (2000-2015)
    • 9.2 Blood Test Reagents Distribution Share (2007-2008)
    • 9.3 Blood Test Reagents, Australia, Company Share (2006-2007)
  • 10 Clinical Chemistry Test Reagents In Australia
    • 10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2015)
    • 10.2 Clinical Chemistry Test Reagents Distribution Share (2007-2008)
    • 10.3 Clinical Chemistry Test Reagents, Australia, Company Share (2006-2007)
  • 11 Genetic Test Reagents In Australia
    • 11.1 Genetic Test Reagents Overall Revenue (2000-2015)
    • 11.2 Genetic Test Reagents Distribution Share (2007-2008)
    • 11.3 Genetic Test Reagents, Australia, Company Share (2006-2007)
  • 12 Immunochemistry Test Reagents In Australia
    • 12.1 Immunochemistry Test Reagents Overall Revenue (2000-2015)
      • 12.1.1 Disease Specific Markers Revenue (2000-2015)
      • 12.1.2 Disease Specific Test Reagents Revenue (2000-2015)
      • 12.1.3 Drug Related Testing Reagents Revenue (2000-2015)
      • 12.1.4 Hormone Related Testing Reagents Revenue (2000-2015)
    • 12.2 Immunochemistry Test Reagents Distribution Share (2007-2008)
    • 12.3 Immunochemistry Test Reagents, Australia, Company Share (2006-2007)
  • 13 Infectious Immunology Test Reagents In Australia
    • 13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2015)
      • 13.1.1 Virology Revenue (2000-2015)
    • 13.2 Infectious Immunology Test Reagents Distribution Share (2007-2008)
    • 13.3 Infectious Immunology Test Reagents, Australia, Company Share (2006-2007)
  • 14 Instruments In Australia
    • 14.1 Instruments Overall Revenue (2000-2015)
    • 14.2 Instruments Distribution Share (2007-2008)
  • 15 Microbiology Test Reagents In Australia
    • 15.1 Microbiology Test Reagents Overall Revenue (2000-2015)
      • 15.1.1 Bacteriology Test Reagents Revenue (2000-2015)
    • 15.2 Microbiology Test Reagents Distribution Share (2007-2008)
    • 15.3 Microbiology Test Reagents, Australia, Company Share (2006-2007)
  • 16 Self Testing In Australia
    • 16.1 Self Testing Overall Revenue (2000-2015)
    • 16.2 Self Testing Distribution Share (2007-2008)
    • 16.3 Self Testing, Australia, Company Share (2006-2007)
  • 17 Overview of Key Companies in Australia In Vitro Diagnostics Market
    • 17.1 F. Hoffmann-La Roche Ltd. Company Profile
      • 17.1.1 Company Overview
      • 17.1.2 Value Chain Analysis
    • 17.2 Abbott Laboratories Company Profile
      • 17.2.1 Company Overview
      • 17.2.2 Value Chain Analysis
      • 17.2.3 Abbott Laboratories Pipeline Products
    • 17.3 Beckman Coulter, Inc. Company Profile
      • 17.3.1 Company Overview
      • 17.3.2 Value Chain Analysis
      • 17.3.3 Beckman Coulter, Inc. Pipeline Products
    • 17.4 Dade Behring Holdings, Inc. Company Profile
      • 17.4.1 Company Overview
    • 17.5 Ortho-Clinical Diagnostics Inc. Company Profile
      • 17.5.1 Company Overview
      • 17.5.2 Ortho-Clinical Diagnostics Inc. Pipeline Products
    • 17.6 bioMerieux S.A. Company Profile
      • 17.6.1 Company Overview
      • 17.6.2 Value Chain Analysis
    • 17.7 Astral Scientific Pty Ltd Company Profile
      • 17.7.1 Company Overview
    • 17.8 Banksia Scientific Pte Ltd Company Profile
      • 17.8.1 Company Overview
    • 17.9 BioLayer Corporation Limited Company Profile
      • 17.9.1 Company Overview
    • 17.10 Cellabs Pty Ltd Company Profile
      • 17.10.1 Company Overview
    • 17.11 Diagnostic Technology Company Profile
      • 17.11.1 Company Overview
    • 17.12 Enterix Australia Pty Ltd Company Profile
      • 17.12.1 Company Overview
    • 17.13 Fermiscan Holdings Limited Company Profile
      • 17.13.1 Company Overview
      • 17.13.2 Fermiscan Holdings Limited Pipeline Products
    • 17.14 GeneWorks Pty. Ltd. Company Profile
      • 17.14.1 Company Overview
    • 17.15 HealthLinx Limited Company Profile
      • 17.15.1 Company Overview
      • 17.15.2 HealthLinx Limited Pipeline Products
    • 17.16 Panbio Limited Company Profile
      • 17.16.1 Company Overview
      • 17.16.2 Panbio Limited Pipeline Products
    • 17.17 Vision BioSystems Ltd Company Profile
      • 17.17.1 Company Overview
    • 17.18 Proteome Systems Limited Company Profile
      • 17.18.1 Company Overview
      • 17.18.2 Proteome Systems Limited Pipeline Products
    • 17.19 Universal Biosensors, Inc. Company Profile
      • 17.19.1 Company Overview
      • 17.19.2 Universal Biosensors, Inc. Pipeline Products
  • 18 Financial Deals Landscape
    • 18.1 Acquisition
      • 18.1.1 QIAGEN Acquires Corbett Life Science
    • 18.2 Equity Offerings
      • 18.2.1 Sonic Healthcare Completes Private Placement Of $283.28 Million
      • 18.2.2 Proteome Systems Completes Private Placement Of $2.17 Million
      • 18.2.3 CSL Completes Private Placement Of $1,517.63 Million
    • 18.3 Partnerships
      • 18.3.1 Circadian Technologies Enters Into An Agreement With Healthscope
      • 18.3.2 ProGenTech Signs Licensing Agreement With Human Genetic Signatures
  • 19 Recent Developments
    • 19.1 Strategy and Business Planning
      • 19.1.1 May 20, 2008: Aperio Opens Operations Center In Australia And New Zealand
    • 19.2 Product Approvals
      • 19.2.1 Dec 15, 2008: Itamar Medical's Endo-PAT2000 Approved For Use By Australian Government's TGA
  • 20 Appendix
    • 20.1 Global Markets Direct Research Methodology
    • 20.2 Coverage
    • 20.3 Secondary Research
    • 20.4 Primary Research
    • 20.5 Models
    • 20.6 Forecasts
    • 20.7 Expert Panel Validation
    • 20.8 Currency Conversion
    • 20.9 Contact Us
    • 20.10 Disclaimer
  • 1 List of Tables
    • Table 1: Healthcare Infrastructure in Australia, 2005
    • Table 2: Healthcare Personnel in Australia, 2005
    • Table 3: Hospital Wards by Specialty in Australia, 2003-2007
    • Table 4: Doctors by Specialty in Australia, 2003-2007
    • Table 5: Conformity Assessment of Medical Devices based Device Class, in Australia, 2007
    • Table 6: Fee for Registered Device in Australia, 2007
    • Table 7: Fee for Device Clinical Trial in Australia, 2007
    • Table 8: Evaluation Fee for High and Low Level Registration of Medical Device in Australia, 2007
    • Table 9: Evaluation Fee for Variation Registration of Medical Device in Australia, 2007
    • Table 10: Fee for Registration of Listed Devices in Australia, 2007
    • Table 11: Fee for Registration of Listed Devices for Export Only in Australia, 2007
    • Table 12: Fee for Registration of Included Devices in Australia, 2007
    • Table 13: Fee for Initial Conformity Assessment of Medical Device in Australia, 2007
    • Table 14: Fee for Medical Device Changes Conformity Assessment in Australia, 2007
    • Table 15: Fee for Medical Device Conformity Assessment Surveillance Audit in Australia, 2007
    • Table 16: Fee for Medical Device Conformity Assessment Review Certificate in Australia, 2007
    • Table 17: Fee for Initial Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 18: Fee for Conformity Assessment of Changes in Medical Device Components in Australia, 2007
    • Table 19: Fee for Abridged Conformity Assessment of Medical Device Components in Australia, 2007
    • Table 20: Fee for Inclusion of Medical Device in the Register in Australia, 2007
    • Table 21: Fee for ARTG Inclusion for Medical Device in Australia, 2007
    • Table 22: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
    • Table 23: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015
    • Table 24: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 25: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 26: In Vitro Diagnostics, Australia Company Share by Revenue ($ mn), 2006-2007
    • Table 27: Blood Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 28: Blood Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 29: Haematology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 30: Haematology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 31: Hemostasis Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 32: Hemostasis Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 33: Blood Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 34: Blood Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 35: Clinical Chemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 36: Clinical Chemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 37: Clinical Chemistry Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 38: Clinical Chemistry Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 39: Genetic Test Reagents, Australia, Revenue ($ mn), Historic, 2000-2008
    • Table 40: Genetic Test Reagents, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Table 41: Genetic Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 42: Genetic Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 43: Immunochemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 44: Immunochemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 45: Disease Specific Markers, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 46: Disease Specific Markers, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 47: Disease Specific Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 48: Disease Specific Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 49: Drug Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 50: Drug Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 51: Hormone Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 52: Hormone Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 53: Immunochemistry Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 54: Immunochemistry Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 55: Infectious Immunology Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 56: Infectious Immunology Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 57: Virology, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 58: Virology, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 59: Infectious Immunology Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 60: Infectious Immunology Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 61: Instruments, Australia, Revenue ($ mn), Historic, 2000-2008
    • Table 62: Instruments, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Table 63: Instruments, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 64: Microbiology Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Table 65: Microbiology Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Table 66: Bacteriology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 67: Bacteriology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 68: Microbiology Test Reagents, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 69: Microbiology Test Reagents, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 70: Self Testing, Australia, Revenue ($ mn), Historic, 2000-2008
    • Table 71: Self Testing, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Table 72: Self Testing, Australia, Distribution Share by Revenue ($mn), 2007-2008
    • Table 73: Self Testing, Australia, Company Share by Revenue ($ mn), 2006-2007
    • Table 74: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 75: Abbott Laboratories Pipeline Products By Development Stage
    • Table 76: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 77: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 78: Abbott Laboratories Pipeline Products By News Summary
    • Table 79: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 80: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 81: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 82: Beckman Coulter, Inc. Pipeline Products By News Summary
    • Table 83: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type
    • Table 84: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage
    • Table 85: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area
    • Table 86: Ortho-Clinical Diagnostics Inc. Pipeline Products By News Summary
    • Table 87: Fermiscan Holdings Limited Pipeline Products by Equipment Type
    • Table 88: Fermiscan Holdings Limited Pipeline Products By Development Stage
    • Table 89: Fermiscan Holdings Limited Pipeline Products By Therapy Area
    • Table 90: Fermiscan Holdings Limited Pipeline Products By Clinical Trials
    • Table 91: Fermiscan Holdings Limited Pipeline Products By News Summary
    • Table 92: HealthLinx Limited Pipeline Products by Equipment Type
    • Table 93: HealthLinx Limited Pipeline Products By Development Stage
    • Table 94: HealthLinx Limited Pipeline Products By Therapy Area
    • Table 95: HealthLinx Limited Pipeline Products By Clinical Trials
    • Table 96: Panbio Limited Pipeline Products by Equipment Type
    • Table 97: Panbio Limited Pipeline Products By Development Stage
    • Table 98: Panbio Limited Pipeline Products By Therapy Area
    • Table 99: Panbio Limited Pipeline Products By News Summary
    • Table 100: Proteome Systems Limited Pipeline Products by Equipment Type
    • Table 101: Proteome Systems Limited Pipeline Products By Development Stage
    • Table 102: Proteome Systems Limited Pipeline Products By Therapy Area
    • Table 103: Proteome Systems Limited Pipeline Products By News Summary
    • Table 104: Universal Biosensors, Inc. Pipeline Products by Equipment Type
    • Table 105: Universal Biosensors, Inc. Pipeline Products By Development Stage
    • Table 106: Universal Biosensors, Inc. Pipeline Products By Therapy Area
    • Table 107: QIAGEN Acquires Corbett Life Science
    • Table 108: Sonic Healthcare Completes Private Placement Of $283.28 Million
    • Table 109: Proteome Systems Completes Private Placement Of $2.17 Million
    • Table 110: CSL Completes Private Placement Of $1,517.63 Million
    • Table 111: Circadian Technologies Enters Into An Agreement With Healthscope
    • Table 112: ProGenTech Signs Licensing Agreement With Human Genetic Signatures
    • Table 113: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in Australia, 2000 - 2005
    • Figure 2: Healthcare Financing Framework in Australia, 2007
    • Figure 3: Healthcare System in Australia, 2007
    • Figure 4: Classification of Medical Devices in Australia, 2007
    • Figure 5: Classification of Noninvasive Devices in Australia, 2007
    • Figure 6: Classification of Invasive Devices in Australia, 2007
    • Figure 7: Classification of Invasive Devices in Australia, 2007
    • Figure 8: Classification of Active Devices in Australia, 2007
    • Figure 9: Classification of Special Medical Devices in Australia, 2007
    • Figure 10: Conformity Assessment Procedure for Medical Devices in Australia, 2007
    • Figure 11: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015
    • Figure 12: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015
    • Figure 13: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 14: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 15: In Vitro Diagnostics, Australia Company Share (%), 2007
    • Figure 16: Blood Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 17: Blood Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 18: Haematology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 19: Haematology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 20: Hemostasis Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 21: Hemostasis Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 22: Blood Test Reagents, Australia, Company Share (%), 2007
    • Figure 23: Clinical Chemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 24: Clinical Chemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 25: Clinical Chemistry Test Reagents, Australia, Company Share (%), 2007
    • Figure 26: Genetic Test Reagents, Australia, Revenue ($ mn), Historic, 2000-2008
    • Figure 27: Genetic Test Reagents, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Figure 28: Genetic Test Reagents, Australia, Company Share (%), 2007
    • Figure 29: Immunochemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 30: Immunochemistry Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 31: Disease Specific Markers, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 32: Disease Specific Markers, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 33: Disease Specific Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 34: Disease Specific Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 35: Drug Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 36: Drug Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 37: Hormone Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 38: Hormone Related Testing Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 39: Immunochemistry Test Reagents, Australia, Company Share (%), 2007
    • Figure 40: Infectious Immunology Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 41: Infectious Immunology Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 42: Virology, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 43: Virology, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 44: Infectious Immunology Test Reagents, Australia, Company Share (%), 2007
    • Figure 45: Instruments, Australia, Revenue ($ mn), Historic, 2000-2008
    • Figure 46: Instruments, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Figure 47: Microbiology Test Reagents, Australia, Revenue ($ mn) by Segment , Historic, 2000-2008
    • Figure 48: Microbiology Test Reagents, Australia, Revenue ($ mn) by Segment , Forecast, 2008-2015
    • Figure 49: Bacteriology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 50: Bacteriology Test Reagents, Australia, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 51: Microbiology Test Reagents, Australia, Company Share (%), 2007
    • Figure 52: Self Testing, Australia, Revenue ($ mn), Historic, 2000-2008
    • Figure 53: Self Testing, Australia, Revenue ($ mn), Forecast, 2008-2015
    • Figure 54: Self Testing, Australia, Company Share (%), 2007
    • Figure 55: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 56: Abbott Laboratories Value Chain Analysis
    • Figure 57: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 58: Biomerieux Sa Value Chain Analysis
    • Figure 59: Global Markets Direct Methodology